Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABCIXIMAB vs ABROCITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABCIXIMAB vs ABROCITINIB: Safety Overview

Metric ABCIXIMAB ABROCITINIB
Total FAERS Reports 322 3,170
Deaths Reported 79 57
Death Rate 24.5% 1.8%
Hospitalizations 100 329
Average Patient Age 60.9 yrs 48.5 yrs
% Female Patients 33.1% 53.9%
FDA Approval Date N/A Jan 14, 2022
Manufacturer N/A U.S. Pharmaceuticals
Route N/A ORAL
Marketing Status Prescription Prescription